Aurora Cannabis Announces Fiscal 2023 Second Quarter Results Cannabis Revenues Up ~20% from Fiscal Q1 2023, Net Revenue¹ of $61.7 Million Achieves Positive Adjusted EBITDA¹ in Line with Prior...
Aurora Cannabis Announces Fiscal 2023 First Quarter Results Reiterates Reaching Adjusted EBITDA Profitability by December 31, 2022 Reaffirms $150 to $170 Million in Annualized Cost Savings Achieved by December 31, 2022; $140 Million Realized to Date Strengthens...
Aurora Cannabis Repurchases ~US$23 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry Balance Sheet Remains in Net Cash Position, Further Strengthened with Accretive Debt Reduction...
Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4%...
Aurora Cannabis Acquires Controlling Interest in Bevo Farms Long Term Investment Expected to Deliver Aurora Immediate Positive Cash Flow Aurora acquires a controlling interest in Bevo; one of the...
Aurora Further Strengthens Balance Sheet with Accretive Debt Reduction EDMONTON, AB, June 3, 2022 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining...
Over-Allotment Option Exercised in Full Strengthened Balance Sheet Eliminates Need to Access the ATM Facility in the Near Future EDMONTON, AB, June 1, 2022 /PRNewswire/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NASDAQ: ACB) (TSX: ACB), the Canadian...
EDMONTON, AB, May 27, 2022 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has announced today that it has amended...
EDMONTON, AB, May 26, 2022 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has...
Aurora Cannabis Announces Fiscal 2022 Third Quarter Results Increasing Original Target for Expense Savings; Management Now Expects $150 to $170 Million in Annualized Cost Savings by H1/2023 versus Stated Target of $60 to $80 Million Reiterating...
Aurora Cannabis Announces Fiscal 2022 Second Quarter Results Global Cannabis Net Revenue of $60.6 Million Adjusted EBITDA Improved by 22% to a loss of $9.0 Million versus Q1 2022...
Aurora Cannabis Announces Fiscal 2022 First Quarter Results Transformation Plan On Track; Actions Taken-to-Date Have Driven Over $33 Million in Annualized Run-Rate Cost Savings Total Cannabis Net Revenue, Net...
Aurora Announces Manufacturing Agreement with The Valens Company New Seasonal Offerings Slated for November Release EDMONTON, AB, Oct. 28, 2021 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX:...
Aurora Cannabis Announces Fiscal 2021 Fourth Quarter Results #1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared to Prior Year; Strong Adjusted Gross...
Aurora Cannabis Announces Fiscal 2021 Third Quarter Results Domestic Medical Net Revenue Steady at $26.9 Million Strong International Medical Net Revenue of $9.4 Million Total Cannabis Net Revenue, Excluding...
Aurora Cannabis Announces Fiscal 2021 Second Quarter Results Total Cannabis Net Revenue of $70.3 Million, Excluding Provisions of $2.7 Million, Up 11% over Q2 2020 Medical Cannabis Net Revenue...
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing EDMONTON, Alberta, Jan. 21, 2021 (GLOBE NEWSWIRE) — Aurora Cannabis Inc. (“Aurora” or the “Company”) has announced today that it...
Aurora Cannabis Closes Previously Announced Upsized Underwritten Public Offering Over-Allotment Option Exercised in Full EDMONTON, Alberta, Nov. 16, 2020 (GLOBE NEWSWIRE) — Aurora Cannabis Inc. (the “Company” or “Aurora”)...
Aurora Cannabis Provides Update on Initiatives to Strengthen Liquidity, Business Transformation Plan and COVID-19 Operational Response Strengthened Cash Position with Plans for Additional Flexibility Given Economic Uncertainty Execution Against...
Aurora Cannabis Announces Share Sale by Founder Terry Booth Transaction in connection with the previously announced transition plan EDMONTON, March 16, 2020 /PRNewswire/ – Aurora Cannabis Inc. (the “Company”...
Aurora Cannabis Announces Second Quarter 2020 Results Net Revenue of $66.6 million, excluding provisions of $10.6 million Net Cannabis Revenue, excluding provisions, of $63.2 million, In Line With Recent Guidance Cash Cost...
Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility Achievement increases total production capacity available to serve international medical markets by 230% Brings Aurora’s total number of...
Initial cannabis 2.0 shipments released to 10 provincial regulators; new products have also been made available for order countrywide by Aurora’s registered medical patients Provides Update on Capital Expenditure...
PAX Labs Partners With Canadian Licensed Producers Aphria, Aurora, Organigram and Supreme Cannabis TORONTO, June 7, 2019 /CNW/ – PAX Labs, Inc., a leading consumer technology brand in cannabis,...
EDMONTON, Sept. 19, 2018 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), today announced that it has completed its previously...
